Applied Therapeutics, Inc.(NASDAQ : APLT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.04%||172.25||0.7%||$1088.53m|
|MRK||Merck & Co., Inc.||-0.13%||76.83||0.7%||$651.89m|
|BMY||Bristol-Myers Squibb Co.||-0.34%||67.92||1.0%||$580.36m|
|LLY||Eli Lilly & Co.||-0.80%||243.36||1.1%||$577.91m|
|NRXP||NRX Pharmaceuticals, Inc.||0.20%||15.18||0.0%||$167.78m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-0.06%||126.06||0.0%||$85.37m|
|NVO||Novo Nordisk A/S||1.32%||92.58||0.1%||$81.36m|
|RPRX||Royalty Pharma Plc||-0.13%||38.20||0.2%||$73.90m|
Applied Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.